News & Perspective

Dec 28, 2012

Dec 28, 2012

Flu markers keep climbing in US and Europe

Editor's Note: The fourth paragraph was revised on Jan 2 to clarify the current situation regarding H3N2 dominance.

(CIDRAP News) – US influenza activity continued its ascent last week, judging from the high volumes of patients seeking care for the disease at doctors' offices, while flu indicators in Europe showed a clear spike, according to the latest surveillance reports.

Nov 20, 2012

Nov 20, 2012

Sequencing supports novel coronavirus's tie to bat strains

(CIDRAP News) – Complete genetic sequencing of a novel coronavrius isolated from a Saudi Arabian man who died in June supports earlier findings that the virus is most closely related to coronaviruses found in bats, according to a report published today in mBio.

Sep 20, 2012

Sep 20, 2012

ECDC studies shed new light on narcolepsy and H1N1 vaccine

(CIDRAP News) – The European Centre for Disease Prevention and Control (ECDC) today confirmed a link between narcolepsy and pandemic 2009 H1N1 vaccination in children in Finland and Sweden, the two countries that originally reported a problem with the vaccine.

Apr 20, 2012

Apr 20, 2012

NIH endorses recommendation to publish H5N1 studies

(CIDRAP News) – The US National Institutes of Health (NIH) has endorsed the recommendations of its biosecurity advisory committee to publish the full versions of two studies describing lab-modified, mammalian-transmissible H5N1 flu viruses, NIH officials announced today.

Apr 17, 2012

Apr 17, 2012

Fouchier plans to flout Dutch export law, publish H5N1 study

(CIDRAP News) – Dutch flu researcher Ron Fouchier, PhD, said he intends to submit a revised manuscript of his controversial mutated-H5N1 study to Science without applying for an export permit, according to a Nature News story today.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»